Loading
journalsJournal
International journal of gynecological cancer
The official journal of the International Gynecologic Cancer Society and ESGO, covering cancers of the ovary, uterus, cervix, vulva and vagina. Read by gynaecological oncologists, medical and radiation oncologists and pathologists.
Also called: International journal of gynecological cancer : official journal of the International Gynecological Cancer SocietyInt J Gynecol CancerIJGC
Overview
International Journal of Gynecological Cancer (IJGC) is the official journal of the European Society of Gynaecological Oncology (ESGO) and the International Gynecologic Cancer Society (IGCS). Elsevier describes it as the primary educational and informational publication on the detection, prevention, diagnosis and treatment of gynaecological malignancies, intended for gynaecologists, medical and radiation oncologists, radiologists, pathologists and research scientists, promoting a multidisciplinary approach and featuring original research, reviews and video articles. The NLM Catalog records a start in 1991 with Blackwell Scientific Publications, a move to Elsevier in 2025 after a period with BMJ, print ceasing in 2018 and MEDLINE indexing.
Publisher
Elsevier · International Gynecologic Cancer Society (IGCS) and European Society of Gynaecological Oncology (ESGO)
Scope
gynaecological oncology
Founded
1991
ISSN
1048-891X
observational202340 citations
ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma
One technology page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
guideline2021changed practice1,458 citations
ESGO/ESTRO/ESP guidelines for the management of endometrial carcinoma (2021)
The adjuvant recommendations on this site's endometrial subtype pages (observation for stage I to II POLE-mutated disease, chemotherapy for p53-abnormal tumours with myometrial invasion, brachytherapy for intermediate risk) follow this guideline.
Ane Gerda Eriksson
President-Elect
Gynaecological oncologyEndometrial cancerSurgical oncology
Oslo gynaecological oncology surgeon at the Norwegian Radium Hospital and President-Elect of ESGO.
Anna Fagotti
Director, Gynecologic Oncology Unit, Gemelli; Professor, Università Cattolica
Ovarian cancer surgeryLaparoscopic assessmentCytoreductive surgery
Surgeon who developed the laparoscopic score for predicting whether ovarian cancer can be fully removed.
Ate van der Zee
Chair of the Executive Board (voorzitter Raad van Bestuur), University Medical Center Groningen
Academic hospital governanceHospital management
Professor who chairs the executive board of University Medical Center Groningen, the academic hospital in the northern Netherlands that houses the UMCG Comprehensive Cancer Center.
Giovanni Scambia
Scientific Director, Fondazione Policlinico Universitario A. Gemelli IRCCS; Professor of Gynaecology
Gynaecological oncologyOvarian cancer surgeryCervical cancer
Giovanni Scambia is a gynaecologic oncologist who leads research at the Gemelli hospital.
Nicole Concin
Coordinator, Gynecologic Cancer Unit; Head, Department of Obstetrics and Gynecology
Gynaecologic oncologyEndometrial cancerOvarian cancer
Gynaecologic oncologist who leads Vienna's women's clinic and is first author of the ESGO/ESTRO/ESP endometrial cancer guidelines.
Thomas Herzog
President
Gynecologic oncologyOvarian cancerClinical trials
Cincinnati gynecologic oncologist who has led the GOG Foundation as President since July 2023.
observationalInternational journal of gynecological cancer 202340 citations
ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma
One technology page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
guidelineInternational journal of gynecological cancer 2021changed practice1,458 citations
ESGO/ESTRO/ESP guidelines for the management of endometrial carcinoma (2021)
The adjuvant recommendations on this site's endometrial subtype pages (observation for stage I to II POLE-mutated disease, chemotherapy for p53-abnormal tumours with myometrial invasion, brachytherapy for intermediate risk) follow this guideline.
Similar pages
- JournalJournal of gynecologic oncology
Shares Gestational trophoblastic neoplasia, Vaginal cancer, Uterine sarcoma, Vulvar cancer.
- InstitutionPoliclinico Universitario A. Gemelli
Shares Anna Fagotti, Giovanni Scambia, European Society of Gynaecological Oncology, Endometrial cancer.
- PersonJalid Sehouli
Shares European Society of Gynaecological Oncology, Endometrial cancer, Cervical cancer, Ovarian cancer.
- TechnologyFertility-sparing hormonal treatment of early endometrial cancer
Shares ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma, Endometrial cancer.
- TreatmentLorigerlimab
Shares Vulvar cancer, Endometrial cancer, Cervical cancer, Ovarian cancer.
- JournalGynecologic Oncology
Shares Ate van der Zee, Vulvar cancer.
- PersonNicoletta Colombo
Shares European Society of Gynaecological Oncology, Cervical cancer, Ovarian cancer.
- TrialEvaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Shares Vaginal cancer, Vulvar cancer, Cervical cancer.